LuminArx Capital Management LP
Position in BCTX — BriaCell Therapeutics Corp.
CIK 1992915
NEW YORK, NY
Position in BCTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$48,600
-$14,250 QoQ
Shares Held
15,000
-62.5% QoQ
Ownership
0.172%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#7
of 18 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCTX Over Time
Shares Held
Position Value (USD)
Derivatives in BCTX
reported options exposure · as of Jun 30, 2026CallValue
$81,000
CallShares
25,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026LuminArx Capital Management LP holds $555,600 across 2 Biotechnology names. BCTX ranks #2 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HUMA |
Humacyte, Inc.
|
650,000 | $507,000 | |
| 2 | BCTX |
BriaCell Therapeutics Corp.
This page
|
15,000 | $48,600 |
All Filings in BCTX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $81,000 | 25,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $48,600 | 15,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $62,850 | 15,000 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||